title: Tricarboxylic acid cycle intermediates during incremental exercise in healthy subjects and in patients with McArdle's disease.
abstract: 1. The importance of the level of tricarboxylic acid cycle intermediates (malate, citrate and fumarate) for energy transduction during exercise has been investigated in six healthy subjects and in two patients with muscle phosphorylase deficiency (McArdle's disease). 2. Healthy subjects cycled for 10 min at low (50 W), moderate [130 +/- 6 W (mean +/- SEM)] and high (226 +/- 12 W) work rates, corresponding to 26, 50 and 80% of their maximal O2 uptake, respectively. Patients with McArdle's disease cycled for 11-13 min at submaximal (40 W) rates, and to fatigue at maximal work rates of 60-90 W. 3. In healthy subjects, phosphocreatine was unchanged during low work rates, but decreased to 79 and 32% of the initial level during moderate and high work rates. In patients with McArdle's disease, phosphocreatine decreased to 82 and 34% of the initial level during submaximal and peak exercise. Muscle lactate increased in healthy subjects during exercise at moderate and high work rates, but remained low in patients with McArdle's disease. 4. In healthy subjects, tricarboxylic acid cycle intermediates were similar at rest and at low work rates (0.48 +/- 0.04 mmol/kg dry weight), but increased to 1.6 +/- 0.2 mmol/kg dry weight and 4.0 +/- 0.3 mmol/kg dry weight at moderate and high work rates. The tricarboxylic acid cycle intermediate level in patients with McArdle's disease was similar to that in healthy subjects at rest, but was markedly reduced during exercise when compared at the same relative intensity. The peak level of tricarboxylic acid cycle intermediates in patients with McArdle's disease was 22% of that in healthy subjects.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.
authors.forename: K
authors.initials: K
authors.lastname: Sahlin
authors.forename: L
authors.initials: L
authors.lastname: Jorfeldt
authors.forename: K G
authors.initials: KG
authors.lastname: Henriksson
authors.forename: S F
authors.initials: SF
authors.lastname: Lewis
authors.forename: R G
authors.initials: RG
authors.lastname: Haller
mesh_terms: D000328:Adult; D000409:Alanine / Q000378:metabolism; D002951:Citrates / Q000378:metabolism; D002952:Citric Acid Cycle; D015444:Exercise / Q000502:physiology*; D005260:Female; D005650:Fumarates / Q000378:metabolism; D018698:Glutamic Acid / Q000378:metabolism; D006012:Glycogen Storage Disease Type V / Q000378:metabolism*; D006801:Humans; D007773:Lactates / Q000378:metabolism; D019344:Lactic Acid; D008293:Malates / Q000378:metabolism; D008297:Male; D018482:Muscle, Skeletal / Q000378:metabolism*; D010725:Phosphocreatine / Q000378:metabolism
chemical_list: D002951:Citrates; D005650:Fumarates; D007773:Lactates; D008293:Malates; D010725:Phosphocreatine; D019344:Lactic Acid; D018698:Glutamic Acid; D000409:Alanine